Sarstedt, a manufacturer and supplier of laboratory equipment and consumables, has established an award that will be given to a Georgia Tech School of Biology graduate student who has made a significant contribution to the biological sciences through Ph.D. research. To be considered a nominating letter must be received from the student's faculty advisor that describes the research accomplished and its significance. Please, send your nominations to the Graduate Committee (c/o Roger Wartell (roger.wartell@biology.gatech.edu). The $250 award will be announced and presented at the SoB Holliday party. Special thanks to Sandra Battista, Sarstedt representative, who helped to establish this award.

Sarstedt, a manufacturer and supplier of laboratory equipment and consumables, has established an award that will be given to a Georgia Tech School of Biology graduate student who has made a significant contribution to the biological sciences through Ph.D. research. To be considered a nominating letter must be received from the student's faculty advisor that describes the research accomplished and its significance. Please, send your nominations to the Graduate Committee (c/o Roger Wartell (roger.wartell@biology.gatech.edu). The $250 award will be announced and presented at the SoB Holliday party. Special thanks to Sandra Battista, Sarstedt representative, who helped to establish this award.

Hispanic Business Inc. awards Georgia Institute of Technology biology graduate student Elizabeth Padilla with Hispanic Business 2008 Entrepreneur of the Year Award. Elizabeth was chosen out four thousand applicants. Elizabeth will be presented the award with three other recipients November 6, 2008 at the EOY (Entrepreneur of the Year) Awards Gala in Los Angeles, California.

Hispanic Business Inc. awards Georgia Institute of Technology biology graduate student Elizabeth Padilla with Hispanic Business 2008 Entrepreneur of the Year Award. Elizabeth was chosen out four thousand applicants. Elizabeth will be presented the award with three other recipients November 6, 2008 at the EOY (Entrepreneur of the Year) Awards Gala in Los Angeles, California.

Link to Nature's Research Highlight: Virology: collective calm

Link to Dr. Weitz's article: Collective decision making in bacterial viruses

Link to Nature's Research Highlight: Virology: collective calm

Link to Dr. Weitz's article: Collective decision making in bacterial viruses

Computer predicts anti-cancer molecules
Link to UPI Article

U.S. scientists have created a computerized method of analyzing cellular activity that correctly predicts the anti-tumor activity of several molecules.

Researchers Jeffrey Skolnick and John McDonald led a Georgia Institute of Technology team in developing the tool, called CoMet, that studies the integrated machinery of the cell, predicting which components can have an effect on cancer.

"This opens up the possibility of novel therapeutics for cancer and develops our understanding of why such metabolites work," said Skolnick.

He said metabolites are small molecules that are naturally produced in cells. Enzymes, the biological catalysts that produce and consume the metabolites, are created according to a cell's genetic blueprints. Importantly, however, he said metabolites can also affect the expression of genes.

"By comparing the gene expression levels of cancer cells relative to normal cells and converting that information into the enzymes that produce metabolites, CoMet predicts metabolites that have lower concentrations in cancer relative to normal cells," the scientists said, adding their findings prove that by adding such putatively depleted metabolites to cancer cells, they exhibit anti-cancer properties.

The research that included Adrian Arakaki, Roman Mezencev, Nathan Bowen and Ying Huang appears in the open access journal Molecular Cancer.

Computer predicts anti-cancer molecules
Link to UPI Article

U.S. scientists have created a computerized method of analyzing cellular activity that correctly predicts the anti-tumor activity of several molecules.

Researchers Jeffrey Skolnick and John McDonald led a Georgia Institute of Technology team in developing the tool, called CoMet, that studies the integrated machinery of the cell, predicting which components can have an effect on cancer.

"This opens up the possibility of novel therapeutics for cancer and develops our understanding of why such metabolites work," said Skolnick.

He said metabolites are small molecules that are naturally produced in cells. Enzymes, the biological catalysts that produce and consume the metabolites, are created according to a cell's genetic blueprints. Importantly, however, he said metabolites can also affect the expression of genes.

"By comparing the gene expression levels of cancer cells relative to normal cells and converting that information into the enzymes that produce metabolites, CoMet predicts metabolites that have lower concentrations in cancer relative to normal cells," the scientists said, adding their findings prove that by adding such putatively depleted metabolites to cancer cells, they exhibit anti-cancer properties.

The research that included Adrian Arakaki, Roman Mezencev, Nathan Bowen and Ying Huang appears in the open access journal Molecular Cancer.

Link to National Science Foundation Article: http://www.nsf.gov/discoveries/disc_summ.jsp?cntn_id=111497

Link to National Science Foundation Article: http://www.nsf.gov/discoveries/disc_summ.jsp?cntn_id=111497